Temple School of Medicine 3401 N. Broad Street, Boyer Building, Suite 473, Philadelphia, Pennsylvania 19140, USA.
Ann Hepatol. 2010 Jan-Mar;9(1):7-14.
Acute liver failure is a rare but often catastrophic illness affecting the liver and multiple organ systems. Patients with acute liver failure require a multidisciplinary approach for adequate management. With improved critical care and the availability of liver transplantation, survival has significantly improved. Hepatic encephalopathy, cerebral edema and infections are the most common complications of acute liver failure. The evaluation requires a diligent search for a specific etiology of the liver failure, since certain causes may respond well to specific pharmacological therapies. Acetaminophen and non-acetaminophen drug-induced hepatotoxicity account for more than 50% of cases of acute liver failure. Assessment of prognosis frequently (at least on a daily basis) by using various prognostic tools, allows the treating team to decide whether or not to proceed with urgent liver transplantation. Artificial liver support devices are still in evaluation and not ready for use in clinical practice. While it is determined whether or not there is sufficient hepatic regeneration, the care of the patient with acute liver failure revolves around managing the dysfunction of multiple extra hepatic systems.
急性肝衰竭是一种罕见但常具灾难性的肝脏和多器官系统疾病。急性肝衰竭患者需要多学科方法进行充分治疗。随着重症监护的改善和肝移植的应用,存活率显著提高。肝性脑病、脑水肿和感染是急性肝衰竭最常见的并发症。评估需要仔细寻找肝衰竭的特定病因,因为某些病因可能对特定的药物治疗反应良好。乙酰氨基酚和非乙酰氨基酚药物诱导的肝毒性占急性肝衰竭病例的 50%以上。通过使用各种预后工具,经常(至少每天)评估预后,使治疗团队能够决定是否进行紧急肝移植。人工肝支持设备仍在评估中,尚未准备好用于临床实践。在确定是否有足够的肝再生时,急性肝衰竭患者的护理围绕着管理多个肝外系统的功能障碍。